A new study evaluating patterns of relapse and progression of disease (R/POD) in patients with multiple myeloma after first-line autologous stem-cell transplant (ASCT) was recently published (Zamarin D, et al. Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients’ monitoring after transplantation. Bone Marrow Transplant. 2012 Aug 13 [Epub ahead of print]).

San Diego, CA—Impressive results from several clinical trials on pomalidomide—a novel immunomodulating drug for multiple myeloma—presented at the 2011 American Society of Hematology annual meeting continue to show promise for this drug.

Results 1 - 3 of 3
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology